Prostate Cancer UK Professionals

prostateukprofs.bsky.social

17 December 2025 19:31

Could targeting MCL1 & BCLXL be effective in advanced #ProstateCancer? Research in @cp-iscience.bsky.social led by Dr Westaby, @juanjimenezvacas.bsky.social, @asharpmedonc.bsky.social & Prof de Bono, supported by our Movember London Centre of Excellence. Grab a ☕ & read: doi.org/10.1016/j.is...

Prostate Cancer UK Professionals

prostateukprofs.bsky.social

31 October 2025 21:03

Our fantastic @prostateukprofs.bsky.social career development fellow @juanjimenezvacas.bsky.social takes a closer look at a potential new treatment approach for #ProstateCancer that has stopped responding to existing therapies ⬇️.

Adam Sharp

asharpmedonc.bsky.social

31 October 2025 21:02

Thank you

Craig Gedye

craiggedye.bsky.social

31 October 2025 21:01

well done and great work congrats to you and @asharpmedonc.bsky.social the team

Prostate Cancer UK Professionals

prostateukprofs.bsky.social

14 October 2025 16:20

Could targeting MCL1 be a new treatment approach for hormone therapy-resistant #ProstateCancer? A study in @natcomms.nature.com by @juanjimenezvacas.bsky.social, @asharpmedonc.bsky.social and the @icr.ac.uk team explores precision therapy strategies. Grab a ☕ and read: doi.org/10.1038/s414...